AMNESTROGEN Drug Patent Profile
✉ Email this page to a colleague
When do Amnestrogen patents expire, and when can generic versions of Amnestrogen launch?
Amnestrogen is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in AMNESTROGEN is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
Summary for AMNESTROGEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 102 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMNESTROGEN at DailyMed |
US Patents and Regulatory Information for AMNESTROGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | AMNESTROGEN | estrogens, esterified | TABLET;ORAL | 083266-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | AMNESTROGEN | estrogens, esterified | TABLET;ORAL | 083266-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | AMNESTROGEN | estrogens, esterified | TABLET;ORAL | 083266-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |